Passage Bio Inc. (PASG) Social Stream



Passage Bio Inc. (PASG): $2.02

0.19 (+10.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PASG to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Passage BIO Inc (PASG) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Passage BIO Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-07 8 $43 $22 $27.857 $3.05 813.34%
2021-11-08 8 $43 $23 $28 $3.05 818.03%
2022-03-03 6 $43 $23 $27.6 $3.05 804.92%
2022-03-14 6 $34 $23 $26.5 $3.05 768.85%

The Trend in the Analyst Price Target


Over the past 39 weeks, PASG's average price target has gone down $4.3.

PASG reports an average of 229.78% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-10 8 45 25 29.71 13.59 118.62%
2021-11-08 5 43 23 28.00 8.89 214.96%
2021-11-08 7 43 23 28.00 8.89 214.96%
2021-11-08 8 43 23 28.60 8.89 221.71%
2022-03-03 6 43 23 27.60 3.05 804.92%

PASG Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 4 1 1 0 0 6

The Trend in the Broker Recommendations


PASG's average broker recommendation rating improved by 0.06 over the prior 151 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Passage BIO Inc's upside potential (average analyst target price relative to current price) is greater than 984.01% of them.
  • Passage BIO Inc's variance in analysts' estimates is lower than -699.14% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Passage BIO Inc's number of analysts covering the stock is higher than 771.21% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Passage BIO Inc's average analyst price target is higher than 642.21% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Passage BIO Inc are OYST, OTLK, and OPT.

What is the outlook for PASG? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5782 seconds.